110 Results for "

AML+cells

" in MedChemExpress (MCE) Product Catalog:
Products (110)

110 Results for "AML+cells" in MCE Product Catalog:

9
9 Publications Verification
Cat. No.: HY-100548
CAS No.: 1346607-05-3
Purity:  98.03%
Target:  

AMPK Autophagy Apoptosis

Research Areas:  

Cancer

GSK621 is a specific AMPK activator, with IC50 values of 13-30 μM for AML cells. GSK621 induces autophagy and apoptosis. GSK621 induces eiF2α phosphorylation-a hallmark of UPR activation .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-112852
CAS No.: 1315330-17-6
Purity:  98.47%
Target:  

Src Apoptosis

Research Areas:  

Cancer

TL02-59 is an orally active, selective Src-family kinase Fgr inhibitor with an IC50 of 0.03 nM. TL02-59 inhibits Lyn and Hck with IC50s of 0.1 nM and 160 nM, respectively. TL02-59 potently suppresses acute myelogenous leukemia (AML) cell growth .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-124629
CAS No.: 2170606-74-1
Purity:  99.48%
Target:  

Apoptosis

Research Areas:  

Cancer

DB2313 is a potent inhibitor of transcription factor PU.1. DB2313 inhibits PU.1-dependent reporter gene transactivation with an IC50 of 5 μM. DB2313 disrupts the interaction of PU.1 with target gene promoters. DB2313 induces apoptosis in acute myeloid leukemia (AML) cells and has anticancer effects .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-112041
CAS No.: 1610964-64-1
Purity:  99.45%
Synonyms: PTC596
Target:  

BMI1 Apoptosis

Research Areas:  

Cancer

Unesbulin (PTC596) is an orally active and selective B-cell-specific Moloney murine leukemia virus integration site 1 (BMI-1) inhibitor. Unesbulin downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia (AML) cells. Unesbulin has anti-leukemic activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-142161
CAS No.: 3007772-60-0
Purity:  99.46%
Target:  

MAGL

Research Areas:  

Cancer

ABD957 is a potent and selective covalent inhibitor of the ABHD17 family of depalmitoylases, with an IC50 of 0.21 μM for ABHD17B. ABD957 can block N-Ras signaling and the growth of NRAS-mutant AML cells .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B1336
CAS No.: 67-45-8
Furazolidone is a monoamine oxidase (MAO) inhibitor with antiproliferative, apoptosis-inducing and differentiation-promoting activities. Furazolidone may inhibit leukemia fusion protein-mediated bone marrow transformation by upregulating the stability of the tumor suppressor protein p53. Furazolidone exhibits anti-leukemic activity in acute myeloid leukemia (AML) cell lines and can be used for anti-AML research [2].
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-30272
CAS No.: 103-16-2
Target:  

Hapten

Research Areas:  

Cancer

Monobenzone is a potent skin depigmenting agent. Monobenzone induces depigmentation and exhibits good potential for vitiligo research. Monobenzone is a potent inhibitor of RNR (Ribonucleotide reductase) enzyme activity by targeting RRM2 (a regulatory small subunit M2 of RNR) protein, and thus has significant anti-leukemia efficacy in vitro and in vivo. Monobenzone inhibits acute myeloid leukemia (AML) cells proliferation and DNA synthesis, induces cell cycle arrest, and Apoptosis .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-13680
CAS No.: 97207-47-1
Purity:  99.91%
Synonyms: Dian III; N-Methylisoindigotin; Natura-α
Meisoindigo (Dian III), a derivative of Indirubin (HY-N0117), halts the cell cycle at the G0/G1 phase and induces apoptosis in primary acute myeloid leukemia (AML) cells. Meisoindigo exhibits high antitumor activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-16172
CAS No.: 791595-09-0
Synonyms: Dimethylamino Parthenolide
Target:  

NF-κB

Research Areas:  

Cancer

DMAPT (Dimethylamino Parthenolide), an analogue of Parthenolide (PTL), is an oral active NF-κB inhibitor, with a LD50 of 1.7 μM for cell population in AML cells. Has potential anti-cancer and anti-metastatic effect .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-160415
CAS No.: 3066823-45-5
Target:  

PROTACs METTL3 Apoptosis

Research Areas:  

Cancer

WD6305 is a potent and selective METTL3-METTL14 PROTAC degrader. WD6305 has DC50 values of 140 nM and 194 nM for METTL3 and METTL14, respectively. WD6305 inhibits m 6A modification and proliferation of AML cells, and induces apoptosis.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-144433
CAS No.: 1403598-56-0
Purity:  99.94%
Target:  

DNA Methyltransferase

Research Areas:  

Infection

DNMT3A-IN-1 (compound 1) is an effective and selective DNMT3A inhibitor. DNMT3A-IN-1 exhibits inhibitory activity against DNMT3A, with KI values ranging from 9.16 to 18.85 μM (AdoMet) and 11.37 to 23.34 μM (poly dI-dC). DNMT3A-IN-1 can induce apoptosis in acute myeloid leukemia (AML) cell lines (Apoptosis) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-160415A
Target:  

PROTACs METTL3 Apoptosis

Research Areas:  

Cancer

WD6305 TFA is a potent and selective METTL3-METTL14 PROTAC degrader. WD6305 TFA has DC50 values of 140 nM and 194 nM for METTL3 and METTL14, respectively. WD6305 TFA inhibits m 6A modification and proliferation of AML cells, and induces apoptosis. WD6305 TFA has antitumor activity .(Pink: UZH2 (HY-115717); Black: Linker; Blue: VHL ligand (HY-150803))
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-129937A
CAS No.: 2417371-71-0
Purity:  99.91%
Research Areas:  

Cancer

GNE-987 is a VHL-dependent BRD4 PROTAC degrader. GNE-987 exhibits picomolar cell BRD4 degradation activity (DC50=0.03 nM for EOL-1 AML cell line). GNE-987 binds equipotently to the BD1 and BD2 bromodomains of BRD4 with low nanomolar affinities (IC50=4.7 and 4.4 nM, respectively). GNE-987 can be used for the research of cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-148422
CAS No.: 1139253-73-8
Purity:  99.40%
Research Areas:  

Cancer

Rohinitib is a potent and specific eIF4A inhibitor. Rohinitib induces cell apoptosis of acute myeloid leukemia (AML) cell lines and reduces the leukemia burden of AML xenograft model. Rohinitib can be used for the research of AML .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-120084
CAS No.: 2052301-24-1
Purity:  99.20%
Target:  

Casein Kinase

Research Areas:  

Cancer

BTX161, a thalidomide analog, is an effective CKIα degrader. BTX161 mediates human AML cell CKIα degradation more effectively than lenalidomide and activates the DNA damage response (DDR) and p53, while stabilizing p53 antagonist MDM2.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-129099A
CAS No.: 15917-65-4
Purity:  99.93%
N-Desmethyltamoxifen hydrochloride is the major metabolite of tamoxifen in humans. N-Desmethyltamoxifen, a poor antiestrogen, is a ten-fold more potent protein kinase C (PKC) inhibitor than Tamoxifen. N-Desmethyltamoxifen hydrochloride is also a potent regulator of ceramide metabolism in human AML cells, limiting ceramide glycosylation, hydrolysis, and sphingosine phosphorylation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-160638
CAS No.: 73768-68-0
Target:  

TET Protein

Research Areas:  

Cancer

NSC-311068 is TET1 inhibitor. NSC-311068 selectively suppress TET1 transcription and 5-hydroxymethylcytosine (5hmC) modification. NSC-311068 represses the level of TET1 expression and the global 5hmC level. NSC-311068 effectively inhibits cell viability in AML cells with high expression of TET1 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-129099
CAS No.: 31750-48-8
N-Desmethyltamoxifen is the major metabolite of tamoxifen in humans. N-Desmethyltamoxifen, a poor antiestrogen, is a ten-fold more potent protein kinase C (PKC) inhibitor than Tamoxifen. N-Desmethyltamoxifen is also a potent regulator of ceramide metabolism in human AML cells, limiting ceramide glycosylation, hydrolysis, and sphingosine phosphorylation .
loading...
    loading...
Cat. No.: HY-159646
CAS No.: 2564486-44-6
BMS-986397 is a potent, selective, and orally active cereblon-based molecular glue degrader of casein kinase 1α (CK1α). BMS-986397 induces apoptosis and cell cycle arrest in acute myeloid leukemia (AML) cells. BMS-986397 is a promising agent for the investigation of AML and high-risk myelodysplastic syndromes (HR-MDS) .
loading...
    loading...
Cat. No.: HY-N0071
CAS No.: 1818-71-9
Synonyms: Isoguanosine
Crotonoside is isolated from Chinese medicinal herb, Croton. Crotonoside inhibits FLT3 and HDAC3/6, exhibits selective inhibition in acute myeloid leukemia (AML) cells. Crotonoside could be a promising new lead compound for the research of AML .
loading...
    loading...